關于摯信資本<\/b><\/p> \n
摯信資本是一家中國領先的成長型股權基金管理公司，專注于優質且具有良好增長潛力的投資機會。我們成立于2006年，現資產管理規模約80億美元，其管理資金主要來自全球領先的大學捐贈基金、退休基金、主權基金及產業戰略伙伴。我們依托對人口、技術和行業結構轉型等長期基本面的深厚見地，采取生態體系驅動的投資理念，深耕于互聯網、內容、教育和醫療領域。我們相信摯信在這些領域所積累的豐富的行業見解和資源能助力我們更好地挖掘并把握獨特的投資機會。<\/p> \n
Trustbridge Partners is a leading growth equity fund that focuses on investing in high-quality growth opportunities in China<\/span>. Founded in 2006, Trustbridge currently manages approximately $8 billion<\/span> in assets from leading university endowments, pension funds, sovereign wealth funds, and strategic industry partners. Our investment philosophy is built upon a fundamental understanding of long-term trends in demographics, technology and structural changes. We adopt a unique ecosystem-driven approach and concentrate in the internet, content, education, and healthcare sectors where we believe our deep insights and strong industry relationships help generate unique investing opportunity sets.<\/p> \n 關于<\/b>General Oriental<\/b><\/p> \n General Oriental is a family investment office that exclusively manages the estate of Sir James Goldsmith<\/span> for the economic benefit of his descendants. Sir James Goldsmith<\/span> (1933-1997) was an English industrialist who made numerous investments in Europe<\/span>, North America<\/span> and Asia<\/span> from the 1950s to 1990s, including Bovril, British-American Tobacco, Newmont Mining, Zee TV, INCO Indonesia and Noble Group. Additional information on Sir James Goldsmith<\/span> can be obtained from the websites of http:\/\/www.sirjamesgoldsmith.com<\/a> and http:\/\/en.wikipedia.org\/wiki\/James_Goldsmith<\/a>. General Oriental manages a multi-billion dollar global investment portfolio across all asset classes, including private equity investments in various countries across the Asia Pacific<\/span> region including China<\/span>, Hong Kong<\/span>, Japan<\/span>, Singapore<\/span>, Thailand<\/span> and Indonesia<\/span>.<\/p> \n 關于金浦健康基金<\/b><\/p> \n 金浦健康基金成立于2015年4月，是金浦投資旗下專注于醫療健康行業股權投資的專業型基金。基金聚焦于生物技術與制藥、醫療器械、醫療服務等大健康細分領域的投資，成立至今投資項目20余個，被投公司均處于行業領先地位。金浦健康基金踐行“分享”與“成長”的企業文化，致力于成為“價值發現者”和“價值創造者”。基金合伙人擁有股權投資和醫療健康領域十五年以上工作經歷，團隊管理的連續兩支基金都獲得了全國社保基金和國家開發銀行的投資，同時也是第一支獲得全國社保基金投資的管理團隊，開創了中國養老金投資PE基金的先河。<\/p> \n GP Healthcare Capital is a subsidiary fund of GP Capital, focusing on private equity investment in the healthcare industry. We are interested in a variety of healthcare sub-sectors, including biotechnology, pharmaceuticals, medical devices, medical services, etc. Founded in April 2015<\/span>, GP Healthcare Capital has created and maintained an extensive portfolio of more than 20 leading companies in the related fields. We practice a corporate culture of “Share and Thrive Together” and are committed to becoming a “value discoverer” and a “value creator”. The founding partners have more than 15 years of experience in equity investment and healthcare industry. Two previous funds managed by our management team were both financed by National Social Security Fund (NSSF) and National Development Bank (NDB), and they are the pioneers to receive investments from NSSF in China<\/span>.<\/p>"];
$("#dvExtra").html(content_array[0]);})();